Sentante’s endovascular robotic surgery platform secures CE mark

Sentante now intends to establish partnerships with hospitals and healthcare providers across Europe to integrate its technology into routine clinical practice. Sentante now intends to establish partnerships with hospitals and healthcare providers across Europe to integrate its technology into routine clinical practice. Sentante completed the first-in-human procedures using its telesurgery robotics platform in July 2024. Credit: Sentante Sentante has gained a CE mark for its endovascular robotic surgery platform, priming the device for commercialisation in Europe. The Lithuania-headquartered company’s system is teleoperated, allowing endovascular procedures to be performed from a remote workstation comprised of a haptic feedback wire and a…

Source: Medical Device Network